Literature DB >> 1293239

Combined radiation and chemotherapy for epidermoid carcinoma of the anal canal.

I H Schneider1, G G Grabenbauer, T Reck, F Köckerling, R Sauer, F P Gall.   

Abstract

Between 1985 and 1992, 46 patients with epidermoid carcinoma of the anal canal were treated prospectively by a protocol of combined radiation and chemotherapy with 5-Fluorouracil and Mitomycin C. The survival rate, NED-survival rate and local tumour control rate were 84%, 71% and 83% at 5 years. Anorectal function was retained in 33 of 41 patients (80%). We observed severe acute toxicity including three deaths, but very little late morbidity. The only marginally significant prognostic factor (P = 0.06) for local tumour control was T-stage. NED-survival was significantly affected (P = 0.02) by reduction of chemotherapy during the second course.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1293239     DOI: 10.1007/bf00341219

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  11 in total

1.  Anal cancer: radiation and concomitant continuous infusion chemotherapy.

Authors:  M Rotman; C S Lange
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-10       Impact factor: 7.038

2.  Epidermoid carcinoma of the anorectum.

Authors:  M W Stearns; S H Quan
Journal:  Surg Gynecol Obstet       Date:  1970-11

3.  Primary radiation therapy in the treatment of anal carcinoma.

Authors:  S T Cantril; J P Green; G L Schall; W C Schaupp
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-09       Impact factor: 7.038

4.  Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases.

Authors:  M Schlienger; C Krzisch; F Pene; J L Marin; B Gindrey-Vie; S Mauban; N Barthelemy; J L Habrand; G Socie; R Parc
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-12       Impact factor: 7.038

5.  [Anal canal carcinoma: diagnosis--therapy--prognosis].

Authors:  G G Grabenbauer; N Wolf; J Dunst; R Sauer
Journal:  Strahlenther Onkol       Date:  1989-12       Impact factor: 3.621

6.  Carcinoma of the anal canal. A clinical and pathologic study of 188 cases.

Authors:  B M Boman; C G Moertel; M J O'Connell; M Scott; L H Weiland; R W Beart; L L Gunderson; R J Spencer
Journal:  Cancer       Date:  1984-07-01       Impact factor: 6.860

7.  Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C.

Authors:  B J Cummings; T J Keane; B O'Sullivan; C S Wong; C N Catton
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-10       Impact factor: 7.038

8.  Epidermoid cancer of the anorectum.

Authors:  D B Frost; P C Richards; E D Montague; G G Giacco; R G Martin
Journal:  Cancer       Date:  1984-03-15       Impact factor: 6.860

9.  Squamous cell carcinoma of the anal canal: treatment by external beam irradiation.

Authors:  F Eschwege; P Lasser; A Chavy; P Wibault; J Kac; P Rougier; C Bognel
Journal:  Radiother Oncol       Date:  1985-02       Impact factor: 6.280

10.  The use of radiation therapy combined with chemotherapy in the management of squamous cell carcinoma of the anus and marginally resectable adenocarcinoma of the rectum.

Authors:  B Sischy
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-09       Impact factor: 7.038

View more
  3 in total

Review 1.  Anal cancer: multimodal therapy.

Authors:  P M Schlag; M Hünerbein
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

2.  Chemo-radiation with or without mandatory split in anal carcinoma: experiences of two institutions and review of the literature.

Authors:  Christoph Oehler; Sawyna Provencher; David Donath; Jean-Paul Bahary; Urs M Lütolf; I Frank Ciernik
Journal:  Radiat Oncol       Date:  2010-05-13       Impact factor: 3.481

3.  Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging.

Authors:  S D Otto; L Lee; H J Buhr; B Frericks; S Höcht; A J Kroesen
Journal:  J Gastrointest Surg       Date:  2009-04-14       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.